Position in AMGN
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$3,230,686
+$233,509 QoQ
Shares Held
9,182
+0.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Reynders McVeigh Capital Management, LLC holds $48,961,420 across 8 Drug Manufacturers - General names. AMGN ranks #5 (6.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
76,014 | $18,580,862 | |
| 2 | NVS |
Novartis AG
|
73,392 | $11,210,628 | |
| 3 | ABBV |
AbbVie Inc.
|
29,052 | $6,318,519 | |
| 4 | LLY |
ELI LILLY & Co
|
5,986 | $5,505,743 | |
| 5 | AMGN |
Amgen Inc
This page
|
9,182 | $3,230,686 | |
| 6 | MRK |
Merck & Co., Inc.
|
22,387 | $2,692,932 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
17,904 | $1,085,877 | |
| 8 | PFE |
Pfizer Inc
|
11,972 | $336,173 |
All Filings in AMGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,230,686 | 9,182 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $2,997,177 | 9,157 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $2,509,040 | 8,891 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $2,526,571 | 9,049 | Shares | Sole | 2025-09-04 | |
| 2025-03-31 | $2,926,700 | 9,394 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $2,460,441 | 9,440 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $3,046,495 | 9,455 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,828,609 | 9,053 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,548,644 | 8,964 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $2,613,493 | 9,074 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $2,454,585 | 9,133 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,846,540 | 8,317 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $1,809,257 | 7,484 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $1,926,727 | 7,336 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $1,663,452 | 7,380 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $1,785,335 | 7,338 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $1,773,991 | 7,336 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $1,658,253 | 7,371 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,584,455 | 7,451 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,882,725 | 7,724 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $1,997,695 | 8,029 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $1,827,404 | 7,948 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $2,117,406 | 8,331 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $1,979,101 | 8,391 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,609,676 | 7,940 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||